Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 27, 2024
Isoniazid
and
rifampicin
co-therapy
are
the
main
causes
of
anti-tuberculosis
drug-induced
liver
injury
(ATB-DILI)
acute
failure,
seriously
threatening
human
health.
However,
its
pathophysiology
is
not
fully
elucidated.
Growing
evidences
have
shown
that
fibroblast
growth
factors
(FGFs)
play
a
critical
role
in
diverse
aspects
pathophysiology.
The
aim
this
study
to
investigate
FGFs
pathogenesis
isoniazid
(INH)
(RIF)-induced
injury.
Through
systematic
screening,
finds
hepatic
FGF1
expression
significantly
downregulated
both
mouse
model
patients
challenged
with
INH
RIF.
Hepatocyte-specific
Fgf1
deficiency
exacerbates
RIF-induced
resulted
from
elevated
bile
acids
(BAs)
synthases
aberrant
BAs
accumulation.
Conversely,
pharmacological
administration
non-mitogenic
analog
-
FGF1ΔHBS
alleviated
via
restoring
homeostasis.
Mechanically,
repressed
hepatocyte
nuclear
factor
4α
(Hnf4α)
transcription
activating
FGF
receptor
4
(FGFR4)-ERK1/2
signaling
pathway,
thus
reducing
synthase.
findings
demonstrate
functions
as
negative
regulator
biosynthesis
protect
against
normalizing
homeostasis,
providing
novel
mechanistic
insights
into
ATB-DILI
potential
therapeutic
strategies
for
treatment
ATB-DILI.
Foods,
Journal Year:
2024,
Volume and Issue:
13(17), P. 2843 - 2843
Published: Sept. 7, 2024
Yellow
tea
(YT),
a
slightly
fermented
with
unique
yellowing
process
and
mellow
taste,
is
becoming
widely
popular.
Currently,
the
YT
includes
bud
yellow
(BYT),
small-leaf
(SYT),
large-leaf
(LYT)
based
on
maturity
of
raw
materials.
Previous
studies
have
shown
that
has
outstanding
potential
in
preventing
metabolic
syndrome.
However,
distinct
effects
mechanisms
different
types
ulcerative
colitis
(UC)
are
still
unclear.
This
study
investigated
continuous
or
intermittent
intervention
three
water
extracts
(YTEs)
dextran
sulfate
sodium
(DSS)-induced
CD-1
mice.
The
results
showed
YTE
significantly
improves
syndrome
DSS-induced
UC
Mechanistic
reveal
YTEs
increase
expression
levels
tight
junction
(TJ)
proteins
reduce
pro-inflammatory
cytokines
colon
by
inactivating
TLR4/NF-κB/NLRP3.
treatment
protected
intestinal
barrier
integrity
reduced
serum
lipopolysaccharide
(LPS)
levels.
Interestingly,
our
indicate
better
alleviating
effect
than
BYT
SYT.
before
DSS
administration
certain
degree
preventive
colitis,
while
after
induction
significant
reversing
damage
caused
DSS.
Our
indicated
drinking
may
therapeutic
UC,
especially
LYT.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(12), P. 2910 - 2910
Published: Dec. 20, 2024
Inflammatory
bowel
disease
(IBD)
is
a
chronic
condition
that
affects
about
7
million
people
worldwide,
and
new
therapies
are
needed.
Understanding
the
complex
roles
bile
acids
(BAs)
play
in
IBD
may
lead
to
development
of
novel
treatments
independent
direct
immunosuppression.
This
review
discusses
latest
discoveries
BAs
pathogenesis
explores
how
these
offer
promising
therapeutic
targets
treat
improve
patient
outcomes.
Several
discussed
include
specific
BA
receptor
(BAR)
agonists,
dietary
therapies,
supplements,
probiotics,
mesenchymal
stem
cell
have
all
been
shown
decrease
activity.
Cells,
Journal Year:
2024,
Volume and Issue:
13(13), P. 1079 - 1079
Published: June 21, 2024
IBD
is
an
uncontrolled
inflammatory
condition
of
the
gastrointestinal
tract,
which
mainly
manifests
in
two
forms:
ulcerative
colitis
(UC)
and
Crohn's
disease
(CD).
The
pathogenesis
appears
to
be
associated
with
abnormal
response
innate
adaptive
immune
cells.
Innate
immunity
cells,
such
as
macrophages,
mast
granulocytes,
can
produce
proinflammatory
(e.g.,
TNF-α)
oxidative
stress
(ROS)
mediators
promoting
intestinal
damage,
their
responses
induce
imbalance
immunity,
leading
production
cytokines
that
increase
abate
barrier
functions,
aggravate
inflammation.
Considering
Ca
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(7), P. 737 - 737
Published: July 3, 2024
Conventional
immunization
methods
such
as
intramuscular
injections
lack
effective
mucosal
protection
against
pathogens
that
enter
through
the
surfaces.
Moreover,
conventional
therapy
often
leads
to
adverse
events
and
compromised
immunity,
followed
by
complicated
outcomes,
leading
need
switch
other
options.
Thus,
a
develop
safe
treatment
with
long-term
beneficial
outcomes
reduce
risk
of
relapse
is
mandatory.
Mucosal
vaccines
administered
across
surfaces,
respiratory
or
intestinal
mucosa,
prompt
robust
localized
systemic
immune
responses
prevent
public
from
acquiring
pathogenic
diseases.
immunity
contains
unique
cell
milieu
selectively
identify
limits
transmission
progression
diseases,
allergic
dermatitis
inflammatory
bowel
disease
(IBD).
It
also
offers
infection
at
site
entry,
enables
clearance
on
induction
ability
shape
regulatory
responses.
Regulatory
T
(Treg)
cells
have
been
promising
strategy
suppress
To
find
advances
in
treatment,
we
investigated
therapeutic
effects
intranasal
pep27
mutant
immunization.
Nasal
protects
but
nasal
antigen
presentation
appears
entail
for
an
adjuvant
stimulate
immunogenicity.
Here,
novel
method
developed
induce
Tregs
via
without
potentially
overcome
diseases
gut
lung
inflammation
using
lung–gut
axis
communication
animal
models.
The
implementation
these
therapies
should
be
preceded
studies
Treg
resilience
clinical
translational
dietary
changes.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 26, 2024
Abstract
Conjugated
bile
acids
(BAs)
are
multi-functional
detergents
produced
in
the
gastrointestinal
(GI)
tract
by
liver
enzyme
acid:amino
acid
N-acyltransferase
(BAAT)
and
microbiome
from
acyltransferase
activity
of
ubiquitous
salt
hydrolase
(BSH).
Humans
with
inflammatory
bowel
disease
(IBD)
have
an
enrichment
both
host
microbially
conjugated
BAs
(MCBAs),
but
their
impacts
on
GI
inflammation
not
well
understood.
We
investigated
role
host-conjugated
dextran
sodium
sulfate
(DSS)
model
colitis
using
a
BAAT
knockout
background.
Baat-/-
KO
mice
severe
phenotypes
DSS
that
were
rescued
supplementation
taurocholate
(TCA).
Gene
expression
histological
analysis
showed
this
rescue
was
likely
due
to
improved
epithelial
barrier
goblet
cell
function.
TCA
also
increased
diversity,
particularly
BA
metabolizing
Lachnospiraceae.
Metabolomics
all
known
forms
including
microbial
sources,
hydrolysis
metabolism
secondary
BAs.
The
ability
improve
pathology
under
despite
its
ready
led
us
investigate
BSH
diverse
gut
bacteria
panel
in
vitro
vivo.
Exposure
17
bacterial
isolates
10
amino
broad
hydrolytic
capacity
depending
bacterium.
Host-produced
MCBAs
SerCA
AlaCA
readily
hydrolyzed,
whereas
GluCA,
AspCA
ThrCA
more
resistant.
This
variability
translated
vivo
where
fed
recalcitrant
GluCA
had
less
production
compared
TCA.
complexity
dysbiosis
inflamed
murine
exploration
BSHs
genes
metagenomic
data
human
IBD
patients.
Certain
bsh
sequences
enriched
diseased
states
Ruminococcus
gnavusEnterocloster
clostridioformis
people
Crohn’s
disease.
Collectively,
study
shows
may
provide
benefits
those
IBD,
is
dictated
delicate
balance
between
conjugation/deconjugation
based
present.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 27, 2024
Isoniazid
and
rifampicin
co-therapy
are
the
main
causes
of
anti-tuberculosis
drug-induced
liver
injury
(ATB-DILI)
acute
failure,
seriously
threatening
human
health.
However,
its
pathophysiology
is
not
fully
elucidated.
Growing
evidences
have
shown
that
fibroblast
growth
factors
(FGFs)
play
a
critical
role
in
diverse
aspects
pathophysiology.
The
aim
this
study
to
investigate
FGFs
pathogenesis
isoniazid
(INH)
(RIF)-induced
injury.
Through
systematic
screening,
finds
hepatic
FGF1
expression
significantly
downregulated
both
mouse
model
patients
challenged
with
INH
RIF.
Hepatocyte-specific
Fgf1
deficiency
exacerbates
RIF-induced
resulted
from
elevated
bile
acids
(BAs)
synthases
aberrant
BAs
accumulation.
Conversely,
pharmacological
administration
non-mitogenic
analog
-
FGF1ΔHBS
alleviated
via
restoring
homeostasis.
Mechanically,
repressed
hepatocyte
nuclear
factor
4α
(Hnf4α)
transcription
activating
FGF
receptor
4
(FGFR4)-ERK1/2
signaling
pathway,
thus
reducing
synthase.
findings
demonstrate
functions
as
negative
regulator
biosynthesis
protect
against
normalizing
homeostasis,
providing
novel
mechanistic
insights
into
ATB-DILI
potential
therapeutic
strategies
for
treatment
ATB-DILI.